- Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer. Harper-Wynne, C.L., Sacks, N.P., Shenton, K., MacNeill, F.A., Sauven, P., Laidlaw, I.J., Rayter, Z., Miall, S., Howes, A., Salter, J., Hills, M.J., Lowe, F.M., A'Hern, R., Nasiri, N., Doody, D., Iqbal, J., Dowsett, M. J. Clin. Oncol. (2002)